D.E. Shaw & Co’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-55,587	Closed	-$559K	–	4027
2021 Q2	$559K	Buy	55,587 +30,587	+122%	+$308K	﹤0.01%	2840
2021 Q1	$247K	Buy	+25,000	New	+$247K	﹤0.01%	2731